Making Markets for Vaccines

Making Markets for Vaccines
Author :
Publisher :
Total Pages : 132
Release :
ISBN-10 : UCSC:32106018146230
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Making Markets for Vaccines by : Owen Barder

Download or read book Making Markets for Vaccines written by Owen Barder and published by . This book was released on 2005 with total page 132 pages. Available in PDF, EPUB and Kindle. Book excerpt: A legacy of our generation -- Ch. 1. We need to invest more in vaccines -- Ch. 2. Promoting private investment in vaccine development -- Ch. 3. A market not a prize -- Ch. 4. Design choices -- Ch. 5. $3 billion per disease -- Ch. 6. Meeting industry requirements -- Ch. 7. How sponsors can do it.


Making Markets for Vaccines Related Books

Making Markets for Vaccines
Language: en
Pages: 132
Authors: Owen Barder
Categories: Business & Economics
Type: BOOK - Published: 2005 - Publisher:

GET EBOOK

A legacy of our generation -- Ch. 1. We need to invest more in vaccines -- Ch. 2. Promoting private investment in vaccine development -- Ch. 3. A market not a p
Priorities for the National Vaccine Plan
Language: en
Pages: 368
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-05-17 - Publisher: National Academies Press

GET EBOOK

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic dec
Creating Markets for New Vaccines: Rationale
Language: en
Pages: 64
Authors: Michael Kremer
Categories: Medical assistance
Type: BOOK - Published: 2000 - Publisher:

GET EBOOK

Creating Markets for New Vaccines: Design issues
Language: en
Pages: 84
Authors: Michael Kremer
Categories: Medical assistance
Type: BOOK - Published: 2000 - Publisher:

GET EBOOK

Creating Markets for New Vaccines
Language: en
Pages: 0
Authors: Michael Kremer
Categories: Medical assistance
Type: BOOK - Published: 2000 - Publisher:

GET EBOOK

Malaria, tuberculosis, and the strains of HIV common in Africa kill approximately 5 million people each year. Yet research on vaccines for these diseases remain